Showing 590 – 600 of 1228 results
-
Tyler Glover
View biography for Tyler Glover, Partner, Managing Director, Private Wealth Management Consulting Services.
-
Ken Langston
View biography for Ken Langston, Partner, Managing Director, Private Wealth Management Branch Leadership.
-
Wrap Up London 2021
For the 11th straight year, William Blair teamed up with the Wrap Up London campaign to support the group’s annual coat drive during the holiday season.
-
Cybersecurity 2020 Trust No One Verify Everyone
The term zero trust has become the next in a long line of popular terms used by cybersecurity companies to associate their offerings with a more sophisticated, next-generation approach.
-
Coalfire and Apax Partners Transaction
William Blair acted as the exclusive financial advisor to Coalfire Systems Inc. (Coalfire), a portfolio company of The Carlyle Group and The Chertoff Group, in connection with its pending acquisition by Apax Partners.
-
Granicus and Harvest Partners
William Blair acted as exclusive financial advisor to Granicus, Inc. (Granicus), a portfolio company of Vista Equity Partners, in connection with its pending investment from Harvest Partners and Vista’s Foundation Fund IV.
-
Ellen Blair Chube Receives Emerging Philanthropist Award
Ellen-Blair Chube, a William Blair partner and a managing director with the firm’s investment banking team, received the emerging philanthropist award from the Association of Fundraising Professionals (AFP) in Chicago at its annual gala.
-
ZipRecruiter Inc Initiation
William Blair initiated research coverage of ZipRecruiter, Inc. (ZIP $20.64). ZipRecruiter is a leading online hiring platform for small and medium-size businesses that streamlines the recruiting process for employers, offering reseller programs, ATS integrations, and an email alert program.
-
Cloudflare Inc Initiation
William Blair & Company initiated research coverage of Cloudflare, Inc. (NET $36.12). The company provides a broad range of network services over its global cloud platform that enhance the security, performance, and reliability of business-critical applications while eliminating the cost and complexity of managing and integrating individual network hardware.
-
Silence Therapeutics plc
William Blair & Company initiated research coverage of Silence Therapeutics plc (SLN $15.50), a clinical-stage biopharmaceutical company focused on developing proprietary GalNAc-conjugated siRNA therapeutics for genetically defined life-threatening disorders.